|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2001;72:18-19
© 2001 The Society of Thoracic Surgeons
ur-Poumon, Blvd Fleming, 25030, Besancon, France
e-mail: chocron@usa.net
Venous thromboembolism is the third most prevalent cardiovascular disease after coronary artery disease and stroke. Remy-Jardin and coworkers [1] reported that only 48% of patients showed complete resolution of their acute thrombotic obstruction and 13% presented chronic thromboembolic changes 11 months after treatment for acute pulmonary embolism.
Thromboembolic pulmonary hypertension has a very poor prognosis: from 30% to 10% 5-year survival according to mean pulmonary artery pressure. Despite promising functional results obtained with
Related Article
Ann. Thorac. Surg. 2001 72: 13-18.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |